Many women experience bladder leakage as they age — sometimes with a cough or sneeze, sometimes with an urgent dash to the bathroom. A new study suggests there’s no one-size-fits-all solution to mixed urinary incontinence, but a tailored approach can help many find the treatment that will work best for them.
Conducted by the Pelvic Floors Disorder Network and funded by the National Institutes of Health, the study, published May 5 in the Journal of the American Medical Association, compared outcomes for mixed urinary incontinence patients after they received either a mid-urethral bladder sling — a surgical procedure — or injectable botulinum toxin A, better known as Botox.
While both treatments improved symptoms for most of the 150 study participants, researchers found no single best option. Instead, the study emphasizes that treatment decisions should be personalized through shared decision-making between patients and doctors, said Christopher Chermansky, a study author and an assistant professor of urology at the University of Pittsburgh School of Medicine.
“We really didn't see one that was the clear front runner. We saw improvements with both treatments, which is great,” but it really comes down to examining specific symptoms and deciding which treatment individual patients are most comfortable with, said Chermansky, who is also a UPMC urological surgeon who has performed both treatments numerous times.
The study’s primary goal was to determine whether starting with one treatment produced better results than the other in patients with mixed incontinence, which involves both stress and urge symptoms. Participants, aged 27 to 87, were divided evenly: Half underwent sling surgery and half received Botox. Patients were permitted to pursue the second treatment later if desired.
A key finding involved the “statistically significant difference between those two crossover rates,” Chermansky said. Specifically, only 15% of those who started with Botox chose to later undergo sling surgery. In contrast, twice as many — 30% — of those who started with the sling opted for Botox later on.
Stress versus urge
According to the Cleveland Clinic, stress incontinence is the most common type of urinary incontinence and can cause sufferers to leak urine during physical exertion — such as jumping or lifting heavy objects — or when coughing, laughing and sneezing. Up to 30% of women are likely to develop stress incontinence sometime in their life, per the clinic. Men can develop the condition too, but it is much less likely.
Meanwhile, urgency — or urge — incontinence causes urine to leak when a patient feels an urgent need to pee. A condition called overactive bladder, which affects how often someone feels the need to urinate, is often associated with urge incontinence, according to the clinic. Additionally, about half of those diagnosed with stress incontinence also suffer from the urge variety.
It’s estimated that more than a third of women older than 65 suffer from mixed urinary incontinence, according to the International Continence Society. By age 80, 20% of women will undergo surgery for stress or mixed incontinence.
The costs — both personal and societal —of incontinence are high. Individually, women who have the condition pay an average of $900 to $4,000 every year for things like supplies, laundry and dry cleaning, according to a study published in the journal Obstetrics & Genecology.
Comparing treatments
“For urge incontinence, there really is no one best treatment,” Chermansky noted. However, Botox may appeal more to patients seeking a minimally invasive procedure that can be done in their doctor’s office. The treatment involves an injection of lidocaine — a pain-numbing agent — and then an injection of Botox directly into the bladder muscle, which helps it to relax, thus reducing the urge to urinate. It also generally reduces involuntary urine leakage, he said.
One drawback to Botox is that some patients experience increased risk for urinary tract infections, according to a Duke Health article. This happens because Botox works by paralyzing parts of the bladder muscle, which can interfere with complete emptying of the bladder.
Botox’s appeal includes avoiding intravenous sedation or general anesthesia and a procedure that requires a trip to an operating room, like the bladder sling.
Sling surgery, however, has its own advantages, Chermansky said. It’s a very common and relatively uncomplicated outpatient surgical procedure that has been shown to have great success in decreasing patients’ stress incontinence symptoms.
It does have a bit of a recovery window: Strenuous activities should be avoided or limited for six to eight weeks after the procedure, he added.
Chermansky emphasized that patients with a predominance of stress symptoms often had more dramatic improvements with the sling. Conversely, those with more urge-related symptoms responded better to Botox — which, notably, is not a standard treatment for stress incontinence.
This distinction suggests that patients may benefit from a more tailored approach. “Instead of just offering both treatments equally, up front you might want to target the Botox in that group,” Chermansky said, referring to patients whose symptoms are dominated by urgency incontinence.
Interpreting crossover rates
While the study did not delve into examining why some patients did or did not pursue a second treatment, Chermansky speculated that patients who began their treatment with the more invasive option — the sling — may have felt less apprehensive about later adding the Botox. In contrast, those who improved with Botox may have been content enough with their progress to forgo surgery.
“I think maybe in the minds of some women, they're like, ‘Maybe I'll just live with my stress incontinence for a little bit longer. I know that the Botox worked, and I'll keep getting the Botox,’” he said.
Botox injections typically last about six to nine months, after which patients would need an additional round. It also does not cure the condition; it simply treats the symptoms, which would potentially require repeated injections for the foreseeable future for patients.
No clear winner, but reassuring results
Ultimately, the study showed both treatments were effective in improving symptoms of mixed incontinence.
There was no significant difference in urge-related outcomes between the groups — further supporting Botox’s strength in treating urgency incontinence. Meanwhile, the researchers did find that women with stress-dominant symptoms improved more significantly with the sling.
“We did [the study] for the purposes of seeing if there was one that had a clear edge, and sometimes studies show equivalence,” Chermansky said. “That’s reassuring. That’s good information to be able to share with patients.”
The bottom line? Both treatments work. But for women suffering from mixed incontinence, determining which treatment to try first should involve a thorough discussion with a knowledgeable physician — one that weighs individual symptoms, risks, lifestyle preferences and long-term goals, Chermansky said.
“Patients can be reassured that, ‘Hey, if you've got stress [incontinence], a sling is great treatment. If you have urge incontinence, then Botox is a great treatment,” he said.







Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.